L-carnitine and the recovery from exhaustive endurance exercise: a randomized, double-blind, placebo-controlled trial
While the weight loss numbers are exciting, having a clinician monitor the quality of that loss is non-negotiable
[Abstract] bioRxiv
However, the agencies analyses at the time were hindered by the small number of reported instances of suicidal thoughts and behaviors, resulting in what the FDA on Monday called considerable uncertainty in the risk estimate. For more clarity on the matter, the agency conducted a meta-analysis of different GLP-1 trials, encompassing more than 90 studies and nearly 108,000 patients
Constipation or diarrhea may occur as GLP-1 slows gastric motility, and the change in eating patterns affects gut transit time
Certain plans may require documentation of previous attempts to lose weight or evidence of obesity-related health concerns before approving support for GLP-1 therapy